Conference
PGI20 Cost-effectiveness of golimumab versus infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis
Authors
Thorlund K; Druyts E; Eapen S; Mills E
Volume
17
Publisher
Elsevier
Publication Date
May 1, 2014
DOI
10.1016/j.jval.2014.03.232
Conference proceedings
Value in Health
Issue
3
ISSN
1098-3015